EU greenlights Wegovy for lowering heart risks

Novo Nordisk’s popular weight loss drug Wegovy just got backing from the European Union’s medical regulator to expand its use to include reducing the risk of serious heart events for people who are overweight or obese. The news opens the door for the highly-coveted weight loss drug to be prescribed to even more…

Read more...